polyarticular Juvenile Idiopathic Arthritis

polyarticular Juvenile Idiopathic Arthritis is the indication for 6 drugs in DrugBank. It is covered by 9 curated, structured indications.

Also known as: Polyarticular Course Juvenile Idiopathic Arthritis · Polyarticular-course Juvenile Idiopathic Arthritis (JIA) · Polyarticular Course Juvenile Idiopathic Arthritis (JIA)
Classified under: Immune System Diseases
Musculoskeletal and Connective Tissue Diseases
Indicated drugs: Abatacept
Adalimumab
Etanercept
Methotrexate
Tocilizumab
Tofacitinib

Resolves to

Vocabularies

MeSHM000754578ICD-10M08SNOMED CT16044751000119106MedDRA10059176UMLSC3495559

What you can answer from here — as of October 23, 2026

6Indicated drugsWith each drug's targets and mechanism

Listed above

9Structured indicationsPopulation, line of therapy, route and combination as fields, not prose

9Clinical trialsPhase, status and sponsor resolved per trial

3Drugs reporting it as an adverse effectWith incidence where the label states it

Which approved drugs for polyarticular Juvenile Idiopathic Arthritis share a target, and which companies have late-stage candidates against it?

Create a free account or log in to explore the full data card.